Advantages of Intrathecal Nalbuphine, Compared with Intrathecal Morphine, After Cesarean Delivery: An Evaluation of Postoperative Analgesia and Adverse Effects

We performed a prospective, randomized, double-blinded, multicenter study to compare the analgesic efficacy and adverse effects of intrathecal nalbuphine, at three different doses, and intrathecal morphine for postoperative pain relief after cesarean deliveries. Ninety healthy patients at full term who were scheduled for elective cesarean delivery with spinal anesthesia were enrolled in the study. They received 10 mg of hyperbaric bupivacaine 0.5% with either morphine 0.2 mg (Group 1), nalbuphine 0.2 mg (Group 2), nalbuphine 0.8 mg (Group 3), or nalbuphine 1.6 mg (Group 4). Only patients in Groups 1 and 2 reported pain during surgery. Postoperative analgesia lasted significantly longer in the morphine group, compared with the nalbuphine groups (P < 0.0001). In the nalbuphine groups, postoperative analgesia lasted longest with the 0.8-mg dose. The additional increase to 1.6 mg did not increase efficacy. The incidence of pruritus was significantly higher in Group 1 (11 of 22), compared with Group 2 (0 of 22, P < 0.0002), Group 3 (0 of 23, P < 0.0001), and Group 4 (3 of 20, P < 0.02). Postoperative nausea and vomiting were more frequent in Group 1 (5 of 22), compared with Group 2 (0 of 22, P < 0.05), Group 3 (0 of 23, P < 0.05), and Group 4 (3 of 23, not significant). There was no maternal or newborn respiratory depression. Neonatal conditions (Apgar scores and umbilical vein and artery blood gas values) were similar for all groups. This study suggests that intrathecal nalbuphine 0.8 mg provides good intraoperative and early postoperative analgesia without side effects. However, only morphine provides long-lasting analgesia. Implications Small doses of intrathecal nalbuphine produce fewer adverse effects, such as pruritus and postoperative nausea and vomiting, compared with intrathecal morphine. This may allow earlier discharge of patients from the recovery room.

[1]  D. Birnbach,et al.  Intrathecal nalbuphine after cesarean delivery: are we ready? , 2000, Anesthesia and analgesia.

[2]  R. Fournier,et al.  INTRATHECAL MORPHINE VERSUS NALBUPHINE FOR POSTOPERATIVE ANALGESIA AFTER TOTAL HIP REPLACEMENT , 1998 .

[3]  E. Crosby,et al.  Treatment of intrathecal morphine-induced pruritus following caesarean section. , 1998, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[4]  J. Jakobsson,et al.  Intrathecal Sufentanil, Fentanyl, or Placebo Added to Bupivacaine for Cesarean Section , 1997, Anesthesia and analgesia.

[5]  D. Amar,et al.  Epidural analgesia for labour and delivery: fentanyl or sufentanil? , 1996, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[6]  J. Eisenach.  Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. , 1994, Anesthesia and analgesia.

[7]  N. R. Connelly,et al.  The use of fentanyl added to morphine-lidocaine-epinephrine spinal solution in patients undergoing cesarean section. , 1994, Anesthesia and analgesia.

[8]  A. Uchiyama,et al.  Low dose intrathecal morphine and pain relief following caesarean section. , 1994, International journal of obstetric anesthesia.

[9]  E. Ratner,et al.  Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. , 1992, Anesthesia and analgesia.

[10]  Lin Ml.  The analgesic effect of subarachnoid administration of tetracaine combined with low dose morphine or nalbuphine for spinal anesthesia , 1992 .

[11]  M. L. Lin.  [The analgesic effect of subarachnoid administration of tetracaine combined with low dose morphine or nalbuphine for spinal anesthesia]. , 1992, Ma zui xue za zhi = Anaesthesiologica Sinica.

[12]  N. Rawal,et al.  Behavioral and histopathologic effects following intrathecal administration of butorphanol, sufentanil, and nalbuphine in sheep. , 1991, Anesthesiology.

[13]  A. Bader,et al.  Perioperative analgesia with subarachnoid fentanyl-bupivacaine for cesarean delivery. , 1989, Anesthesiology.

[14]  H. S. Chadwick,et al.  Intrathecal and epidural morphine sulfate for post-cesarean analgesia--a clinical comparison. , 1988, Anesthesiology.

[15]  N. Rawal,et al.  Combined Intrathecal Morphine and Bupivacaine for Cesarean Section , 1987, Anesthesia and Analgesia.

[16]  L. Ty,et al.  [Postoperative pain relief with various epidural narcotics: demerol, butorphanol, nalbuphine, and morphine]. , 1988 .

[17]  J. Moore,et al.  Mini‐Dose Intrathecal Morphine for the Relief of Post‐Cesarean SectionPain: Safety, Efficacy, and Ventilatory Responses to Carbon Dioxide , 1988, Anesthesia and analgesia.

[18]  J. J. Wang,et al.  [Postoperative pain relief with various epidural narcotics: demerol, butorphanol, nalbuphine, and morphine]. , 1988, Ma zui xue za zhi = Anaesthesiologica Sinica.

[19]  T. Yaksh,et al.  In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. , 1984, The Journal of pharmacology and experimental therapeutics.

[20]  T. Yaksh,et al.  The analgetic effects of an intrathecally administered partial opiate agonist, nalbuphine hydrochloride. , 1982, European journal of pharmacology.